ຄຸນນະພາບຄືຊີວິດ — Laos Alliance Pharmaceutical Group

ລາວ/中文/EN

ຮ່ວມເປັນພັນທະມິດ
BARINIX 4mg
Rx
ພູມຄຸ້ມກັນວິທະຍາ & ໂຣກຜິວໜັງ

BARINIX 4mg

Baricitinib
Generic (INN)
Baricitinib
Strength
4 mg
Packaging
30 ເມັດ/ກວດ.
Indication
ພະຍາດຂໍ້ອັກເສບຣູມາໂຕອດ, ໄວຣັດໂຄໂຣນາ 2019 (COVID-19), ພະຍາດຜົມຮົ່ງເປັນຢ່ອມ.
Registration No.
To be added
Package Insert
English & Lao (PDF)
Documents
Registration certificateTo be added
Medicine safety & reporting

More in ພູມຄຸ້ມກັນວິທະຍາ & ໂຣກຜິວໜັງ

View all →
ALITOFATIB
ALITOFATIB
Tofacitinib citrate
ALIRUXOLITINIB
ALIRUXOLITINIB
Ruxolitinib
ALIFOTATINI
ALIFOTATINI
Fostamatinib
ALIDEUCRAVA
ALIDEUCRAVA
Deucravacitinib
About AllianceLeadershipVision & MissionHistoryGroup StructureOur ResponsibilityCertifications & Licenses
PharmaceuticalsAlliance Regenerative CentreAnimal HealthSupplementsCosmeticsHousehold & HygieneChemicalsMedical DevicesBrowse all products →
Manufacturing & Innovation overviewManufacturing CapabilitiesManufacturing NetworkResearch & DevelopmentQuality & GMPIntegrated Value ChainAlliance Regenerative Centre
Business Solutions overviewContract ManufacturingPrivate LabelDistributionGovernment & InstitutionalInternational PartnershipsBecome a PartnerPartnerships
Company NewsInvestmentsEventsPress ReleasesProduct Safety
ContactLocationsCareers
Become a partner
EN·ລາວ·中文